How to treat severe symptomatic structural valve deterioration of aortic surgical bioprosthesis: transcatheter valve-in-valve implantation or redo valve surgery?
Authors:
- 2 June 2018
- journal article
- review article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 54 (6) , 977-985
Abstract
The optimal management of aortic surgical bioprosthesis presenting with severe symptomatic structural valve deterioration is currently a matter of debate. Over the past 20 years, the number of implanted bioprostheses worldwide has been rapidly increasing at the expense of mechanical prostheses. A large proportion of patients, however, will require intervention for bioprosthesis structural valve deterioration. Current options for older patients who often have severe comorbidities include either transcatheter valve-in-valve (TVIV) implantation or redo valve surgery. The emergence of TVIV implantation, which is perceived to be less invasive than redo valve surgery, offers an effective alternative to surgery for these patients with proven safety and efficacy in high-risk patient groups including elderly and frail patients. A potential caveat to this strategy is that results of long-term follow-up after TVIV implantation are limited. Redo surgery is sometimes preferable, especially for young patients with a smaller-sized aortic bioprosthesis. With the emergence of TVIV implantation and the long experience of redo valve surgery, we currently have 2 complementary treatment modalities, allowing a tailor-made and patient-orientated intervention. In the heart team, the decision-making should be based on several factors including type of bioprosthesis failure, age, comorbidities, operative risk, anatomical factors, anticipated risks and benefits of each alternative, patient’s choice and local experience. The aim of this review is to provide a framework for individualized optimal treatment strategies in patients with failed aortic surgical bioprosthesis.Keywords
This publication has 55 references indexed in Scilit:
- Long-term results of the Medtronic Mosaic porcine bioprosthesis in the aortic positionThe Journal of Thoracic and Cardiovascular Surgery, 2014
- Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve ReplacementNew England Journal of Medicine, 2012
- Valve-in-Valve Transcatheter Aortic Valve Implantation for Degenerated Bioprosthetic Heart ValvesJACC: Cardiovascular Interventions, 2011
- Redo Aortic Valve Surgery: Early and Late OutcomesThe Annals of Thoracic Surgery, 2011
- Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo SurgeryNew England Journal of Medicine, 2010
- Reoperative Valve Surgery in the Elderly: Predictors of Risk and Long-Term SurvivalThe Annals of Thoracic Surgery, 2010
- Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National DatabaseThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Reoperation of the Aortic Valve in OctogenariansThe Annals of Thoracic Surgery, 2006
- Reoperation is not an independent predictor of mortality during aortic valve surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2006
- Operative risk of reoperative aortic valve replacementThe Journal of Thoracic and Cardiovascular Surgery, 2005